Income Statement Supermax Corporation
Equities
7106
MYL7106OO007
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.130 MYR | -3.42% |
|
-5.83% | -15.04% |
Feb. 11 | Supermax Prices Bonus Warrants Issue | MT |
Nov. 28 | Tranche Update on Supermax Corporation Berhad's Equity Buyback Plan announced on April 23, 2024. | CI |
Fiscal Period: June | 2014 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.13B | 7.16B | 2.69B | 821M | 646M | |||||
Total Revenues | 2.13B | 7.16B | 2.69B | 821M | 646M | |||||
Cost of Goods Sold, Total | 1.02B | 1.61B | 1.41B | 868M | 703M | |||||
Gross Profit | 1.11B | 5.56B | 1.28B | -47.35M | -57.06M | |||||
Selling General & Admin Expenses, Total | 136M | 190M | 172M | 147M | 130M | |||||
Depreciation & Amortization - (IS) | 61.67M | 68.78M | 73.86M | 85.37M | 68.41M | |||||
Other Operating Expenses | 220M | 282M | -109M | -138M | -112M | |||||
Other Operating Expenses, Total | 418M | 542M | 136M | 94.51M | 86.54M | |||||
Operating Income | 692M | 5.02B | 1.14B | -142M | -144M | |||||
Interest Expense, Total | -17.08M | -8.11M | -5.71M | -7.22M | -5.23M | |||||
Net Interest Expenses | -17.08M | -8.11M | -5.71M | -7.22M | -5.23M | |||||
Income (Loss) On Equity Invest. | 18.13M | 35.05M | -11.44M | -6.8M | -3.53M | |||||
Other Non Operating Income (Expenses) | - | - | - | - | - | |||||
EBT, Excl. Unusual Items | 693M | 5.04B | 1.12B | -156M | -152M | |||||
Asset Writedown | -12.91M | -22.02M | -63.51M | -33.62M | -27.14M | |||||
EBT, Incl. Unusual Items | 680M | 5.02B | 1.06B | -189M | -180M | |||||
Income Tax Expense | 145M | 1.09B | 302M | -18.07M | 3.63M | |||||
Earnings From Continuing Operations | 535M | 3.93B | 757M | -171M | -183M | |||||
Net Income to Company | 535M | 3.93B | 757M | -171M | -183M | |||||
Minority Interest | -9.98M | -113M | -38.22M | 30.55M | 7.51M | |||||
Net Income - (IS) | 525M | 3.82B | 719M | -141M | -176M | |||||
Net Income to Common Incl Extra Items | 525M | 3.82B | 719M | -141M | -176M | |||||
Net Income to Common Excl. Extra Items | 525M | 3.82B | 719M | -141M | -176M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.2 | 1.47 | 0.27 | -0.05 | -0.07 | |||||
Basic EPS - Continuing Operations | 0.2 | 1.47 | 0.27 | -0.05 | -0.07 | |||||
Basic Weighted Average Shares Outstanding | 2.61B | 2.6B | 2.64B | 2.64B | 2.57B | |||||
Net EPS - Diluted | 0.2 | 1.47 | 0.27 | -0.05 | -0.07 | |||||
Diluted EPS - Continuing Operations | 0.2 | 1.47 | 0.27 | -0.05 | -0.07 | |||||
Diluted Weighted Average Shares Outstanding | 2.61B | 2.6B | 2.64B | 2.64B | 2.57B | |||||
Normalized Basic EPS | 0.16 | 1.17 | 0.25 | -0.03 | -0.03 | |||||
Normalized Diluted EPS | 0.16 | 1.17 | 0.25 | -0.03 | -0.03 | |||||
Dividend Per Share | - | 0.04 | 0.11 | 0.04 | - | |||||
Payout Ratio | - | 2.72 | 37.09 | -95.05 | -52.24 | |||||
American Depositary Receipts Ratio (ADR) | 10 | 10 | 10 | 10 | 10 | |||||
Supplemental Items | ||||||||||
EBITDA | 751M | 5.08B | 1.21B | -63.4M | -83.77M | |||||
EBITA | 692M | 5.02B | 1.14B | -142M | -144M | |||||
EBIT | 692M | 5.02B | 1.14B | -142M | -144M | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 21.38 | 21.71 | 28.54 | 9.54 | -2.02 | |||||
Total Current Taxes | 146M | 1.18B | 226M | -6.28M | 8.44M | |||||
Total Deferred Taxes | -583K | -89.25M | 76.46M | -11.79M | -4.82M | |||||
Normalized Net Income | 423M | 3.04B | 664M | -66.87M | -87.72M | |||||
Interest on Long-Term Debt | 127K | 659K | 734K | 1.12M | 1.54M | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | 3.43M | 3.26M | 12M | 10.35M | 11.46M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - |